Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens | Zendy

Dominik Arbon | Zendy; Kateřina Ženíšková | Zendy; Karolína Šubrtová | Zendy; Jan Mach | Zendy; Jan Štursa | Zendy; Marta Machado | Zendy; Farnaz Zahedifard | Zendy; Tereza Leštinová | Zendy; Carolina Hierro-Yap | Zendy; Jiřı́ Neužil | Zendy; Petr Volf | Zendy; Markus Ganter | Zendy; Martin Zoltner | Zendy; Alena Zı́ková | Zendy; Lukáš Werner | Zendy; Róbert Šuťák | Zendy

Open Access

Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens

Author(s) -

Dominik Arbon,

Kateřina Ženíšková,

Karolína Šubrtová,

Jan Mach,

Jan Štursa,

Marta Machado,

Farnaz Zahedifard,

Tereza Leštinová,

Carolina Hierro-Yap,

Jiřı́ Neužil,

Petr Volf,

Markus Ganter,

Martin Zoltner,

Alena Zı́ková,

Lukáš Werner,

Róbert Šuťák

Publication year - 2022

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00727-22

Subject(s) - biology , drug repositioning , trypanosoma brucei , drug discovery , drug , atovaquone , pharmacology , mitochondrion , drug resistance , plasmodium falciparum , bioinformatics , microbiology and biotechnology , malaria , immunology , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research